###begin article-title 0
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 263 269 263 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 445 451 445 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
Neoplasia can be driven by mutations resulting in dysregulation of transcription. In the mesenchymal neoplasm, aggressive fibromatosis, subtractive hybridization identified sterile alpha motif domain 9 (SAMD9) as a substantially down regulated gene in neoplasia. SAMD9 was recently found to be mutated in normophosphatemic familial tumoral calcinosis. In this study, we studied the gene structure and function of SAMD9, and its paralogous gene, SAMD9L, and examined these in a variety of species.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 360 366 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 526 532 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 536 543 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 735 741 732 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 769 778 766 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 794 800 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 860 866 857 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 240 245 <span type="species:ncbi:10090">mouse</span>
###xml 345 350 <span type="species:ncbi:9606">human</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
SAMD9 is located on human chromosome 7q21.2 with a paralogous gene sterile alpha motif domain 9 like (SAMD9L) in the head-to-tail orientation. Although both genes are present in a variety of species, the orthologue for SAMD9 is lost in the mouse lineage due to a unique genomic rearrangement. Both SAMD9 and SAMD9L are ubiquitously expressed in human tissues. SAMD9 is expressed at a lower level in a variety of neoplasms associated with beta-catenin stabilization, such as aggressive fibromatosis, breast, and colon cancers. SAMD9 and SAMD9L contain an amino-terminal SAM domain, but the remainder of the predicted protein structure does not exhibit substantial homology to other known protein motifs. The putative protein product of SAMD9 localizes to the cytoplasm. In vitro data shows that SAMD9 negatively regulates cell proliferation. Over expression of SAMD9 in the colon cancer cell line, SW480, reduces the volume of tumors formed when transplanted into immune-deficient mice.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 213 216 <span type="species:ncbi:10116">rat</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 249 254 <span type="species:ncbi:10090">mouse</span>
SAMD9 and SAMD9L are a novel family of genes, which play a role regulating cell proliferation and suppressing the neoplastic phenotype. This is the first report as far as we know about a human gene that exists in rat, but is lost in mouse, due to a mouse specific rearrangement, resulting in the loss of the SAMD9 gene.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 378 379 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 380 381 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 553 554 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 868 869 856 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 870 871 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1087 1092 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COX-2</italic>
###xml 1094 1099 1082 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RHAMM</italic>
###xml 1101 1106 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MMP-3</italic>
###xml 1108 1115 1096 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TIMP-1 </italic>
###xml 1119 1125 1107 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PAI-1 </italic>
###xml 1197 1198 1185 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1199 1200 1187 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
Neoplasia can be driven by a variety of mechanisms. In many cases, oncogenic mutations result in the dysregulation of transcription. This is the case in mutations resulting in beta-catenin stabilization in tumors, as stabilized beta-catenin activates transcription factors in the Tcf/Lef family. These transcription factors regulate gene expression in a tissue specific manner [1,2]. Aggressive fibromatosis, also known as desmoid tumor, is a locally invasive soft tissue tumor composed of a clonal proliferation of mesenchymal, fibroblast-like, cells [3]. Somatic mutations in either the Adenomatous Polypisis Coli (APC) or beta-catenin genes, resulting in the stabilization of beta-catenin protein, are present in the majority of lesions. This gives aggressive fibromatosis tumor cells a proliferative advantage through Tcf/Lef dependent transcriptional activation [4,5]. There are a variety of lines of evidences suggesting that differentially expressed genes in aggressive fibromatosis are involved in the development of this tumor. For instance, the differentially expressed genes, COX-2, RHAMM, MMP-3, TIMP-1 and PAI-1 modulate the size or number of aggressive fibromatosis tumor that form [6-9].
###end p 9
###begin p 10
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 341 344 341 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 380 386 380 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 562 568 562 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 593 599 593 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
To determine how differentially regulated genes contribute to the neoplastic phenotype in aggressive fibromatosis, suppression subtractive hybridization was used to compare gene expression differences between cell cultures derived from an aggressive fibromatosis tumor with an APC mutation and the same cells after transfection of wild-type APC. In this comparison, we found that SAMD9 was one of the most highly differentially regulated genes, and was upregulated with transfection of the wild-type APC. This study focuses on the gene structure and function of SAMD9 and its paralogous gene, SAMD9L.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
SAMD9 is differentially regulated in aggressive fibromatosis
###end title 12
###begin p 13
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 571 573 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 574 576 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 652 656 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 716 720 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 878 881 875 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC</italic>
###xml 929 933 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
Primary cell cultures from an aggressive fibromatosis tumor harbouring a truncating APC mutation were established. These were transfected with either a wild-type APC gene or a control vector, and successful transfection verified using immunohistochemistry. These cell cultures were established for a previous study to determine the role of the interaction between APC and beta-catenin in the regulation of cell proliferation in aggressive fibromatosis. The transfection conditions, mutational analysis, and results of proliferation studies have been previously reported [10,11]. RNA from the cells derived from an aggressive fibromatosis tumor with an APC mutation and the same cells after transfection of wild-type APC were compared using suppression subtractive hybridization. Both forward (cells transfected with a control vector compared to cells transfected with wild-type APC) and reverse (cells transfected with wild-type APC compared to cells transfected with a control vector) subtractions were conducted. Clones were identified, and verified using Northern blot. The most differentially expressed clones were sequenced and their identity searched using GenBank.
###end p 13
###begin p 14
###xml 481 487 481 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD</italic>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 730 736 730 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 774 780 774 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 844 850 844 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 854 861 854 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 906 913 906 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 945 951 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 962 963 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 136 141 <span type="species:ncbi:9606">human</span>
###xml 881 886 <span type="species:ncbi:9606">human</span>
In this comparison, the most differentially regulated gene in the reverse subtraction was a novel gene that was initially identified on human chromosome 7 using GenBank sequence data. Both 5'- and 3'- rapid amplification of cDNA ends (RACE) using the sequence of the 200 bp clone isolated from suppression subtractive hybridization, as well as analysis of EST in the region were undertaken to identify the full length of this gene. Subsequent to the start of this work, Strausberg et al identified a gene in this region using high through put analysis of EST's and designed the gene sterile alpha motif domain 9 (SAMD9) [12]. During this analysis, we also found a nearby gene, which was also subsequently identified by Strausberg et al as sterile alpha motif domain 9 like (SAMD9L) [12]. Using a search of the DNA sequence database in GenBank, SAMD9 and SAMD9L were found to match human chromosome 7q21.2. SAMD9L is located 5' upstream from the SAMD9 gene (Fig. 1). Both genes are coded by the reverse strand with a head to tail orientation.
###end p 14
###begin title 15
Structure of SAMD9 and its paralogue - SAMD9L
###end title 15
###begin p 16
###xml 77 83 77 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 705 711 705 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 843 847 843 847 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TATA</bold>
###xml 1043 1049 1043 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1223 1229 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
Compiling all of the sequence data, we located the most 5'- end sequence for SAMD9 in a 5'- RACE clone, and the most 3'- end sequence for SAMD9 in one of the EST clones [GenBank: ] [see Additional file 1]. Using primers corresponding to the sequences of the most 5'- and 3'- ends of the SAMD9 gene, a predicted 7 kb transcript was amplified from an aggressive fibromatosis tumor cDNA. The full-length of this transcript, the longest transcript that we found, was sequenced [GenBank: ]. The cDNA sequence of SAMD9 gene has 6847 bp with a poly-A signal (AATAAA) at 6831 bp downstream from the transcriptional start point (Fig. 1A). Mapping this cDNA sequence to the genomic DNA sequence in the GenBank, the SAMD9 gene is 18505 bp in length and contains three exons (161 bp, 101 bp and 6585 bp in length, respectively). There is a TATA signal (CCTATATTCT) at -75 bp and five predicted Lef/Tcf binding elements [(C,G) (A,T) (A,T)CAAA(G,C)] at -11440 bp, -10247 bp, -8014 bp, -4788 bp and -3321 bp. The clones isolated from 5'- and 3'- RACE of the SAMD9 gene were sequenced. Comparing the 5'- and 3'- RACE sequences to the genomic DNA sequence from GenBank, different transcription initiation sites and polyadenylation sites of SAMD9 are noted, and there are at least two alternative splices.
###end p 16
###begin p 17
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 133 138 133 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 284 285 284 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 320 327 320 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 433 440 433 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 786 790 786 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TATA</bold>
During the analysis of EST sequences near the initial clone, we identified a second gene,SAMD9L, which is located 12740 bp distal to SAMD9. Using the sequences from the most 5'- and 3'- EST in the region [Celera Database: THC 511215 and THC 513290, respectively] [see Additional file 1], the full-length sequence of the SAMD9L was amplified from an aggressive fibromatosis tumor cDNA, and sequenced [GenBank: ]. The cDNA sequence of SAMD9L gene has 5821 bp with a poly-A signal (AATAAA) at 5659 bp downstream from the transcriptional start point (Fig. 1B). Mapping this cDNA sequence to the genomic DNA sequence in GenBank, the SAMD9L gene is 17583 bp in length, including six exons (152 bp, 59 bp, 132 bp, 148 bp, 102 bp and 5228 bp in length, respectively). There is a TATA signal (TCTATACTTC) at -73 bp and two predicted Lef/Tcf binding elements [(C,G) (A,T) (A,T)CAAA(G,C)] at -49139 bp and -3661 bp.
###end p 17
###begin p 18
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 74 81 74 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 403 409 403 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 413 419 413 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 436 441 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
There are alternatively spliced transcripts in both SAMD9 [GenBank: ] and SAMD9L [GenBank: , ] [see Additional file 1]. These alternative splices lead to either inclusion or exclusion of an exon due to the usage of a different 5' donor splice site or a different 3' acceptor splice site. This alternative splicing also changes the internal coding region due to an in-frame insertion or deletion in both SAMD9 and SAMD9L. In the case of SAMD9, non-canonical dinucleotides AT and TC are used as donor and acceptor splice sites for intron 3, and there is an in-frame canonical pair of the donor and acceptor (GT and AG) splice sites near by. This alternative splicing changes the internal coding region due to an in-frame deletion, leading to the exclusion of sequence coding for a putative protein structure domain - sterile alpha motif (SAM) domain near the N-terminus.
###end p 18
###begin p 19
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 854 860 854 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 904 908 904 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Smg </italic>
###xml 920 922 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 943 949 943 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1183 1185 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
The putative protein structures of both genes were determined using the open reading frame finder program on the National Center for Biotechnology Information (NCBI) website [13], and an open reading frame was identified in the last exon of both genes. The two genes share 78% homology at the DNA sequence level in this exon. The putative protein sequences were analyzed using the Conserved Domain search program in NCBI website [14] for SAMD9, the Motif Scan program from Swiss Institute of Bioinformatics [15-17] and the Predict Protein server from European Molecular Biology Laboratory [18] websites for SAMD9L. Both protein products contain a sterile alpha motif (SAM) domain near the N-terminal region. Otherwise, there is no close homology to other well-characterized proteins or protein motifs. Based on a comparison of the SAM domain sequence of SAMD9 to the homology modeling of the RNA-binding Smg SAM domain [19], the SAM domain of SAMD9 lacks the residues that are essential for binding RNA, while it has 98% sequence homology with the Ephrin-B2-receptor SAM domain, which forms homo-oligomerization and provides a platform for the formation of larger protein complexes [20].
###end p 19
###begin title 20
SAMD9 and SAMD9L are ubiquitously expressed
###end title 20
###begin p 21
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 380 385 380 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 595 602 595 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 258 263 <span type="species:ncbi:9606">human</span>
###xml 418 423 <span type="species:ncbi:9606">human</span>
The expected 7 kb transcript of SAMD9 was identified by Northern analysis using RNA from different age placentas and a 1729 bp PCR amplified probe encompassing the 3'UTR (Fig. 2A). The expression pattern of SAMD9 in multiple tissues was investigated using a human multiple tissue cDNA panel (Clontech, USA) and RT-PCR. The primers were designed to recognize sequences at 3'UTR of SAMD9. Expression was detected in all human adult, fetal and tumor tissues that were tested, except for fetal brain. Only a very low signal was detected in skeletal muscle (Fig. 2B). Using the sequences at 3'UTR of SAMD9L as primers, SAMD9L was also found to be expressed in all tissues, except for the tumor types, colon cancer (CX-1), breast cancer (GI-101) and pancreatic cancer (GI-103) (Fig. 2B).
###end p 21
###begin title 22
SAMD9 and SAMD9L are expressed at lower levels in tumors
###end title 22
###begin p 23
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 162 168 162 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 412 418 412 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 586 588 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 605 611 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 722 724 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1018 1025 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1282 1289 1280 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1403 1410 1401 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1553 1555 1549 1551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1611 1618 1607 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1692 1694 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 1868 1874 1864 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1937 1944 1933 1940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1494 1502 <span type="species:ncbi:9606">patients</span>
To determine the level of expression of SAMD9 in neoplasia, semi-quantitative RT-PCR and real-time quantitative PCR were performed using the sequence at 5'UTR of SAMD9 as a sense primer and a sequence at the beginning of the open reading frame of SAMD9 as an anti-sense primer. Expression was compared between tumor and normal control tissues in cases of aggressive fibromatosis, breast cancer and colon cancer. SAMD9 was expressed at a lower level (about 33% the level for normal control tissues) in aggressive fibromatosis (32.22% +/- 29.18% vs 100%, p < 0.05 for real-time PCR, Fig. 3A). Expression of SAMD9 was lower in 20% cases of breast cancer and 35% cases of colon cancer than in the normal control tissues (Fig. 3C). In three cases of colon cancer, there was no RT-PCR product detected. However, there was no significant difference in expression between colon cancers and normal control tissues or breast cancers and normal control tissues when analysed as a group using real-time PCR. Expression studies of SAMD9L were also conducted using a sequence at 5'UTR which is common for all of the splice variants except one, as a sense primer and sequence at the beginning of the open reading frame as an anti-sense primer. There was no statistically significant difference in SAMD9L expression between aggressive fibromatosis or colon cancer and normal control tissues. However, the expression of SAMD9L was lower in breast cancers than in healthy breast epithelial tissues from the same patients (2.81% +/- 2.40% vs 100%, n = 10, p < 0.001, Fig. 3B). There was no significant difference in expression of SAMD9L between aggressive fibromatosis samples and normal controls tissues (Fig. 3D). While two genes are expressed at a lower level in tumors, there is a discrepancy between the levels of expression of the two genes in different tumor types. For instance, SAMD9 is expressed at lower levels in aggressive fibromatosis, while SAMD9L is not.
###end p 23
###begin title 24
SAMD9 is a cytoplasmic protein
###end title 24
###begin p 25
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B&#8211;F</xref>
###xml 188 191 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
In order to investigate the cellular localization of the putative SAMD9 protein, the open reading frame of the SAMD9 gene was cloned, an N-terminal EGFP tag was added and subcloned into a CMV driven vector pLP-EGFP-C1 (Clontech, USA). This vector was transfected into Cos-1 cells, and using an antibody to EGFP, the fusion protein was detected as a 200 kDa band (Fig. 4A). To determine its localization in a variety of cell types, it was transfected into a human fetal fibroblast cell line, MRC-5, and a colon cancer cell line, SW480. The EGFP fusion protein was detected diffusely in the cell cytoplasm (Fig. 4B-F).
###end p 25
###begin title 26
RNAi for SAMD9 can be used to down regulate its expression
###end title 26
###begin p 27
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 207 213 207 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 592 593 592 593 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 602 605 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 688 694 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
RNA interference was utilized to study the cellular function of SAMD9. RNA interference was designed by searching the public available sequence database to find a 19 bp oligonucleotide sequence specific for SAMD9 and inserting into a pSUPER-RNAi-EGFP expression vector to generate the SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9). One of the sequences is 846 bp after the start of translation, and other is 2371 bp after the start of translation. The pSUPER-RNAi-EGFP expression vector was generated based on pEGFP-C1 (Clontech, USA) and pSUPER [21]. A nucleotide substitution from G to A at the 9th position of this 19 bp oligonucleotide results in abolishing of its specificity to SAMD9 and was used as negative control after subcloned into a pSUPER-RNAi-EGFP expression vector to generate the negative control vector (pSUPER-RNAi-SAMD9-mut9).
###end p 27
###begin p 28
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 172 178 172 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 241 247 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 361 367 361 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 467 473 467 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 726 732 726 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 806 812 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 922 928 922 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 969 975 969 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
SAMD9 expression reduced by RNA interference vector for SAMD9 was tested by co-transfection of an N-terminal EGFP tagged SAMD9 expression vector with either one of the two SAMD9 RNA interference vectors, RNA interference vector with mutated SAMD9 sequence to null its function as negative control, or its control empty vector into Cos-1 cells. The reduction of SAMD9 expression was confirmed using Western blot with anti-GFP (Santa Cruz, USA) for the fusion putative SAMD9 protein. A 90% reduction in expression of SAMD9 fusion protein by RNA interference was detected as measured using densitometry (Fig. 5A). The RNA interference vector that express EGFP was also expressed in SW480 cells along with an N-terminal HA tagged SAMD9 expression vector or its control vector. A 90% reduction in expression of SAMD9 fusion protein by RNA interference was detected (data not shown). Activity of the RNA interference vector for SAMD9 was further verified by the reduction of SAMD9 RNA expression in MRC-5 cells (Fig. 5B).
###end p 28
###begin title 29
SAMD9 regulates cell proliferation and apoptosis
###end title 29
###begin p 30
###xml 109 111 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 155 161 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 277 283 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 325 328 320 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 328 334 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 385 388 378 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd </sup>
###xml 388 394 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 478 480 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 680 686 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 866 872 851 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 970 976 953 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1173 1179 1154 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1283 1289 1260 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
Because beta-catenin stabilization is known to regulate fibroblast proliferation, motility and invasiveness [11], we studied the effect of down-regulating SAMD9 on these parameters. Proliferation rate, as measured by BrdU incorporation, was increased after RNA interference of SAMD9 in MRC-5 cells (12.5% +/- 2.66% with the 1st SAMD9 RNA interference vector, 12.2% +/- 1.63% with the 2nd SAMD9 RNA interference vector, and 7.5% +/- 1.29% with the control vector, p < 0.01, Fig. 5C). There was not a statistical difference in cell motility as measured by the number of cells passing through the membrane of the culture insert (1.7 +/- 0.65 or 2.3 +/- 1.31 with RNA interference of SAMD9 vector vs 0.67 +/- 0.65 with control vector). Cell invasion was increased, as measured by the number of cells passing through the membrane of the Matrigel invasion chambers, after SAMD9 expression was decreased in MRC-5 cells by RNA interference (16 +/- 5.19 with RNA interference of SAMD9 vector vs 5.7 +/- 1.73 with control vector, p < 0.05). These studies were also undertaken in Cos-1 cells, and showed a similar reduction in proliferation rate after over-expression of the putative SAMD9 protein in Cos-1 cells (20.7% +/- 21.9% vs 76.8% +/- 20.2%, p < 0.005). Taken together, this shows that SAMD9 plays a role regulating cell proliferation.
###end p 30
###begin p 31
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 351 353 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 584 586 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 728 730 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 821 827 811 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 905 911 893 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
To explore the effect in neoplasia, cells from the SW480 colon cancer cell line were transfected with a SAMD9 expression vector to determine if increasing expression of this gene would suppress the neoplastic behavior in these cells. Upon transfection of the construct, cell proliferation was reduced (25.6% +/- 3.3% vs 46.2% +/- 9.4%, p < 0.01, Fig. 6A). Cell invasion index calculated as the ratio of the total number of nuclei counted in the membrane for invasion assay to that in the membrane for motility assay was reduced (0.0335 +/- 0.0203 vs 0.0779 +/- 0.0183, p < 0.05, Fig. 6B), while cell apoptosis, as indirectly measured by relative caspase-3 activity was increased (253.11% +/- 45.90% of baseline, p < 0.005, Fig. 6C). The relative caspase-3 activity was also reduced in Cos-1 cells after expression of the SAMD9 siRNA construct (53.76% +/- 0.99% of the baseline, p < 0.01). Thus expressing SAMD9 at higher levels causes cell effects which would be expected to suppress the neoplastic phenotype.
###end p 31
###begin title 32
SAMD9 regulates tumor growth
###end title 32
###begin p 33
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 360 362 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 382 383 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 407 409 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 446 448 440 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 467 468 459 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 493 495 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E</xref>
###xml 520 526 512 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 588 594 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 716 722 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 765 767 755 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 783 784 771 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 333 342 <span type="species:ncbi:10090">nude mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 739 748 <span type="species:ncbi:10090">nude mice</span>
To investigate the role of SAMD9 in tumor growth, the colon cancer cell line, SW480, was transfected with SAMD9 expression vector or its control empty vector. The stably transfected SW480 cells were injected into the immune deficient mice. The tumor volume of the xenograft from SW480 cells over-expressing SAMD9 was reduced in both nude mice (62.5 +/- 73.5 mm3 vs 162.5 +/- 61.7 mm3, n = 4, p < 0.05, Fig. 6D) and NOD-SCID mice (62.4 +/- 20.3 mm3 vs 98.6 +/- 17.1 mm3, n = 21, p < 0.01, Fig. 6E). To verify the role of SAMD9 on neoplasia, we performed experiments when the expression of SAMD9 was lowered using RNA interference. The tumor volume of the xenograft from SW480 cells expressing the RNA interference of SAMD9 was increased in nude mice (310 +/- 19.6 mm3 vs 270 +/- 24 mm3, n = 5, p < 0.05).
###end p 33
###begin title 34
Orthologous genes of SAMD9 and SAMD9L
###end title 34
###begin p 35
###xml 42 48 42 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 52 59 52 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 153 160 153 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 348 349 348 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 610 612 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 651 657 651 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 661 668 661 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 791 797 791 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 801 808 801 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 982 988 982 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 992 998 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 1267 1269 1267 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 811 822 <span type="species:ncbi:9598">chimpanzees</span>
###xml 824 828 <span type="species:ncbi:9615">dogs</span>
###xml 833 837 <span type="species:ncbi:10116">rats</span>
###xml 850 857 <span type="species:ncbi:9031">chicken</span>
###xml 1338 1348 <span type="species:ncbi:7227">Drosophila</span>
###xml 1350 1360 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
###xml 1364 1369 <span type="species:ncbi:4932">yeast</span>
The orthologous genes were identified for SAMD9 and SAMD9L by searching the NR and swissprot databases for best reciprocal matches using human SAMD9 and SAMD9L protein sequences. Genome sequences for all species available were searched by BLAT at the University of California at Santa Cruz genome browser [22]. The results were summarized in Table 1 and the phylogram [see Additional File 1] was constructed using multiple sequence alignment of orthologous genes identified with ClustalW program from European Bioinformatics Institute website [23]. The default parameters from website documentation were used [24]. Based on their sequence similarity, SAMD9 and SAMD9L appear to have originated from a common ancestor by an ancient gene duplication. Since there are orthologous genes of both SAMD9 and SAMD9L in chimpanzees, dogs and rats, but not in chicken, frog or fish species, this duplication event likely occurred after the mammalian radiation. The genomic structures of both SAMD9 and SAMD9L, including the order and orientation of genes within the genomic region and the relative size of the intergenic region, are conserved in all available mammalian genome sequences including opossum, indicating the gene duplication event occurred between 175 to 200 MYA [25]. No evidence for either gene was found in lower eukaryotes such as Drosophila, C. elegans or yeast.
###end p 35
###begin title 36
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
SAMD9 is lost in the mouse lineage
###end title 36
###begin p 37
###xml 72 78 72 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 329 335 329 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 478 484 478 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 743 749 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 759 766 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 1088 1094 1088 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1098 1105 1098 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1239 1240 1239 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1267 1268 1267 1268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 300 305 <span type="species:ncbi:9606">human</span>
###xml 367 372 <span type="species:ncbi:10090">mouse</span>
###xml 430 435 <span type="species:ncbi:9606">human</span>
###xml 437 442 <span type="species:ncbi:10090">mouse</span>
###xml 447 450 <span type="species:ncbi:10116">rat</span>
###xml 508 513 <span type="species:ncbi:10090">mouse</span>
###xml 544 549 <span type="species:ncbi:10090">mouse</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 803 808 <span type="species:ncbi:10090">mouse</span>
###xml 847 852 <span type="species:ncbi:10090">mouse</span>
###xml 964 967 <span type="species:ncbi:10116">rat</span>
###xml 1114 1118 <span type="species:ncbi:10116">rats</span>
###xml 1336 1341 <span type="species:ncbi:9606">human</span>
###xml 1378 1383 <span type="species:ncbi:9606">Human</span>
There were several overlapping ESTs matching the open reading frame for SAMD9L, and no ESTs corresponding to the open reading frame for SAMD9 in the mouse genome. This was confirmed by bioinformatic searches of all genomic sequences and partial genome sequences (EST libraries). The 168 kb region in human chromosome 7, in which SAMD9 is located, has no match in the mouse genome. A syntenic map of the region was constructed for human, mouse and rat. A break of synteny at the SAMD9 locus was determined in mouse, with distal genes mapping to mouse chromosome 6, and the proximal genes mapping to mouse chromosome 5. The mouse specific rearrangement resulted in new centromere formation at the site of breakage and the subsequent loss of the SAMD9 gene. The SAMD9L region contains numerous gaps in the mouse genome assembly, and an enrichment of mouse specific segmental duplications (Fig. 7, also see Additional file 1). The relatively poor draft quality of the rat genome does not allow for high resolution mapping of this locus, but there is evidence to support the existence of both SAMD9 and SAMD9L genes in rats with no large genomic rearrangements, segmental duplications or breaks in synteny although numerous gaps do exist (Fig. 7, also see Additional file 1). There are no gaps or segmental duplications at this locus in the human genome, determined by searching the Human Genome Segmental Duplication Database.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 56 63 56 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 268 275 268 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 406 412 406 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 447 456 447 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 141 146 <span type="species:ncbi:9606">human</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
###xml 631 640 <span type="species:ncbi:10090">nude mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 743 752 <span type="species:ncbi:10090">nude mice</span>
Here we identified a novel gene SAMD9 and its paralogue SAMD9L located in human chromosome 7q21.2. These genes are expressed ubiquitously in human tissues. SAMD9 is expressed at a lower level in aggressive fibromatosis and some cases of breast and colon cancer, while SAMD9L is expressed at a lower level in breast cancer, compared to normal control tissues from the same patients. The putative protein of SAMD9 is localized in the cytoplasm. Our in vitro data suggests SAMD9 regulates cell proliferation rate in both normal and tumor cell lines. Over-expression of SAMD9 in SW480 cells reduced the volume of tumors that formed in nude mice and NOD-SCID mice, while the decreased expression in SW480 cells increased the tumor volume formed in nude mice suggesting a role suppressing the neoplastic phenotype.
###end p 39
###begin p 40
###xml 33 39 33 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 316 322 316 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 460 467 460 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 566 572 566 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 310 315 <span type="species:ncbi:10090">mouse</span>
###xml 364 367 <span type="species:ncbi:10116">rat</span>
###xml 411 414 <span type="species:ncbi:10116">rat</span>
###xml 446 449 <span type="species:ncbi:10116">rat</span>
Very recently, it was found that SAMD9 is mutated in the inherited condition, normophosphatemic familial tumoral calcinosis [26]. In the work of Topaz et al, there is a likely inadvertent error, as when comparing the protein sequences in the publication with the swissProt/NCBI database, it was found that the mouse SAMD9 sequence reported is actually a predicted rat SAMD9 protein sequence [GenBank: ] and the rat SAMD9 sequence reported is the rat predicted SAMD9L protein sequence [GenBank: ]. While conclusions in their manuscript on the species conservation of SAMD9 are incorrect, the occurrence of soft tissue lesions in this inherited condition supports our notion that SAMD9 plays an important role in cell processes that are important in neoplasia.
###end p 40
###begin p 41
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 110 116 110 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 468 474 468 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 819 824 819 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 996 1002 996 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
There are alternatively spliced transcripts in both SAMD9 and SAMD9L. The mechanism for alternative splice of SAMD9 is unusual in that it uses the non-canonical dinucleotides AT and TC as donor and acceptor splice sites for intron 3, and there is an in-frame canonical pair of the donor and acceptor (GT and AG) splice sites near by. Although only the canonical GT-AG, and the non-canonical GC-AG and AT-AC pairs can recruit the splicing machinery effectively, Burset et al suggested that the other non-canonical pairs can function exclusively in association with a canonical pair, which shares its properties with the neighbour, as some kind of parasitic splice sites [27]. This alternative splice results in the in-frame deletion of the sequence coding for the sterile alpha motif (SAM) domain near the N-terminus of SAMD9. Although it is only detected in a quarter of the normal and tumor tissues tested, it has potential to play a dominate-negative role in the functioning of the main common SAMD9 transcript with the SAM domain. The alternative splicing increases the functional complexity of this novel gene, but the function significance of these alternative splicing variants needs further investigation.
###end p 41
###begin p 42
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 352 358 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
While we did not investigate the regulation of expression in SAMD9 and SAMD9L, there are Lef/Tcf binding elements predicted in the genomic sequence upstream of the transcriptional start point for both genes. We also found that the expression of these genes is disregulated in neoplasms driven by beta-catenin mediated signaling. Although this suggests SAMD9 may be regulated by beta-catenin, formal promoter studies are needed to verify this possibility.
###end p 42
###begin p 43
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Smg </italic>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
There is an N-terminal sterile alpha motif (SAM) domain in the predicted putative proteins of SAMD9 and SAMD9L. The SAM domain sequence of SAMD9 was compared using the homology modeling of the RNA-binding Smg SAM domain [19]. This showed that the SAM domain lacks the residues that are essential for binding RNA, while it has 98% sequence homology with the Ephrin-B2-receptor SAM domain, which is important in homo-oligomerization and acts as a platform for the formation of larger protein complexes [20]. This raises the possible that SAMD9 may have a similar function participating in protein complexes.
###end p 43
###begin p 44
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDK6</italic>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDK6 </italic>
###xml 323 329 323 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 482 488 482 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 536 542 536 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 347 352 <span type="species:ncbi:10090">mouse</span>
###xml 420 430 <span type="species:ncbi:9598">chimpanzee</span>
###xml 432 435 <span type="species:ncbi:9615">dog</span>
###xml 441 444 <span type="species:ncbi:10116">rat</span>
###xml 510 515 <span type="species:ncbi:10090">mouse</span>
###xml 557 562 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:9606">human</span>
###xml 648 651 <span type="species:ncbi:10116">rat</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
Human chromosome 7q21.2 is located at an evolutionary breakpoint between mouse chromosome 5 and 6, which was localized after human-mouse comparative mapping of the genomic region containing CDK6, i.e., human genes' centromeric to CDK6 map to proximal mouse chromosome 5, while those telomeric to the open reading frame for SAMD9L, map to proximal mouse chromosome 6 [28]. Based on our bioinformatics analysis, there are chimpanzee, dog, and rat orthologous genes for both SAMD9 and SAMD9L. Although there is a mouse ortholog of SAMD9L, SAMD9 is lost in the mouse genome. This is the first report as far as we know about a human gene that exists in rat, but is lost in mouse.
###end p 44
###begin p 45
###xml 32 39 32 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">COL21A1</italic>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">STK17A</italic>
###xml 132 138 132 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GPR145</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ARH I</italic>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1016 1023 1016 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 1024 1028 1024 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Estm</italic>
###xml 1097 1099 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1124 1128 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Estm</italic>
###xml 1171 1177 1171 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 1262 1267 1262 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 1295 1301 1295 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 5 10 <span type="species:ncbi:9606">human</span>
###xml 279 284 <span type="species:ncbi:10090">mouse</span>
###xml 289 292 <span type="species:ncbi:10116">rat</span>
###xml 474 479 <span type="species:ncbi:9606">human</span>
###xml 520 525 <span type="species:ncbi:10090">mouse</span>
###xml 569 574 <span type="species:ncbi:10090">mouse</span>
###xml 637 640 <span type="species:ncbi:10116">rat</span>
###xml 649 654 <span type="species:ncbi:10090">Mouse</span>
###xml 655 660 <span type="species:ncbi:9606">human</span>
###xml 686 691 <span type="species:ncbi:9606">human</span>
###xml 692 695 <span type="species:ncbi:10116">rat</span>
###xml 753 758 <span type="species:ncbi:10090">mouse</span>
###xml 773 778 <span type="species:ncbi:10090">mouse</span>
###xml 853 858 <span type="species:ncbi:9606">human</span>
###xml 863 866 <span type="species:ncbi:10116">rat</span>
###xml 891 896 <span type="species:ncbi:9606">human</span>
###xml 901 904 <span type="species:ncbi:10116">rat</span>
###xml 1002 1007 <span type="species:ncbi:10090">mouse</span>
###xml 1077 1082 <span type="species:ncbi:10090">mouse</span>
###xml 1165 1170 <span type="species:ncbi:10090">mouse</span>
###xml 1256 1261 <span type="species:ncbi:9606">human</span>
###xml 1319 1324 <span type="species:ncbi:10090">mouse</span>
Four human genes, collagen XXI (COL21A1), serine-threonine kinase family member (STK17A), G-protein coupled receptor family member (GPR145) and ras homologue gene family member I (ARH I), located in regions corresponding to evolutionary breakpoints in rodents are absent in both mouse and rat genomes due to an unexpected consequence of evolutionary chromosome rearrangement at the evolutionary breakpoint and lost during evolution [29]. SAMD9 locates in a 168 kb region on human chromosome 7, which has no match in the mouse genome, and at the break in synteny in the mouse genome. But there is no break in synteny at this locus in the rat genome. Mouse-human breakpoint absent in the human-rat comparison suggests the rearrangement is specific to the mouse lineage, i.e. mouse-specific breakpoint. There are no segmental duplications at this locus in human and rat genomes after search of human and rat segmental duplication databases. Fluorescent in situ hybridization (FISH) using a BAC containing mouse EST for SAMD9L (Estm25) revealed a single strong signal at 6A1-A2 in mouse chromosome 6 [28]. Since the sequence of Estm25 maps to the open reading frame of mouse SAMD9L, and it has very high homology with the sequence at the open reading frame of human SAMD9, the FISH result indicates SAMD9 does not exist in mouse.
###end p 45
###begin p 46
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 285 291 285 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 934 935 934 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1005 1010 1005 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdk6 </italic>
###xml 1039 1045 1039 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 1108 1113 1108 1113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 1354 1356 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
###xml 547 552 <span type="species:ncbi:10090">mouse</span>
###xml 596 601 <span type="species:ncbi:10090">mouse</span>
###xml 629 634 <span type="species:ncbi:10090">mouse</span>
###xml 944 949 <span type="species:ncbi:10090">mouse</span>
###xml 1138 1143 <span type="species:ncbi:10090">mouse</span>
###xml 1272 1275 <span type="species:ncbi:10116">rat</span>
###xml 1318 1321 <span type="species:ncbi:10116">rat</span>
Here we propose a model, which is mouse specific, for the genomic rearrangement, break in synteny, centromere formation and deletion of SAMD9 although it is very difficult to properly estimate all those events. We highlight a mouse specific rearrangement, resulting in the loss of the SAMD9 gene. Segmental duplications have been shown to mediate chromosomal rearrangements via non-allelic homologous recombination [30], and it has been shown that there is a significant correlation between low copy repeats and break of synteny between human and mouse [31]. Taken together, the existence of the mouse specific rearrangement and mouse specific low copy repeats, it would suggest a causative role, but no direct conclusions can be made. It has also been shown that centromeric regions act as reservoirs for recently duplicated sequence and this may account for the enrichment of low copy repeats at this locus [32]. As shown in Figure 7, in the mouse genome, two segmental duplications, one centromeric to cdk6 and the other centromeric to SAMD9L, may mediate chromosomal breakage with subsequent deletion of SAMD9, and the centromeres of mouse chromosome 6 and 5 are formed at the sites of breakage. There is no evidence of the segmental duplications at this locus in the rat genome after searching the Evan Eichler's rat segmental duplication database [33].
###end p 46
###begin title 47
Conclusion
###end title 47
###begin p 48
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 417 423 417 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 322 325 <span type="species:ncbi:10116">rat</span>
###xml 342 347 <span type="species:ncbi:10090">mouse</span>
###xml 358 363 <span type="species:ncbi:10090">mouse</span>
SAMD9 and SAMD9L are expressed ubiquitously in human tissues, but they are expression at lower levels in neoplasia. SAMD9 regulates cell proliferation and apoptosis, and decreases tumor growth of colon cancer cell line in immune deficient mice. This is the first report as far as we know about a human gene that exists in rat, but is lost in mouse, due to a mouse specific rearrangement, resulting in the loss of the SAMD9 gene. Although these novel genes were identify in the study of a relatively rare disorder, aggressive fibromatosis, these genes seem to play a role regulating cell growth in a variety of tumor types.
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Cell lines, human and mouse materials
###end title 50
###begin p 51
###xml 395 399 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 440 444 440 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 553 561 <span type="species:ncbi:9606">patients</span>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
SW480, MRC-5, Cos-1 and NIH3T3 cell lines were obtained from the American Tissue and Cell Collection. For each experiment in which cell lines were used for a quantitative assay, the experiment was conducted nine independent times, each time on a different day. The RNA populations used for subtractive hybridization were prepared from cells derived from an aggressive fibromatosis tumor with an APC mutation after transfection of wild-type APC or a control vector as previously reported [11]. Cells, tumor and normal control tissues were collected from patients with sporadic aggressive fibromatosis, colon cancer, and breast cancer while the patients were under surgical excision of the tumors. All of the samples were cryopreserved as soon as possible after resection and stored in liquid nitrogen vapor for later nucleic acids extraction. The local ethical approvals for this research were obtained.
###end p 51
###begin title 52
Suppression subtractive hybridization
###end title 52
###begin p 53
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 209 213 209 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APC </italic>
###xml 888 894 888 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
Suppression subtractive hybridization was used to compare the gene expression differences in a cell culture derived from an aggressive fibromatosis tumor with an APC mutation after transfection of a wild type APC to the same cell culture after transfection of a control vector using Clontech PCR-select cDNA subtraction kit (K1804-1, Clontech, CA, USA). Both forward (cDNA from cells transfected with control vector was subtracted by cDNA from cells transfected with wild-type APC) and reverse (cells transfected with wild-type APC was subtracted by cells transfected with control vector) subtractions were conducted. There were eight genes identified in the forward subtraction and 16 genes in the reverse subtraction that were found to be differentially expressed, based on the screening of dot blots containing 196 clones in the forward and reverse subtracted libraries, respectively. SAMD9 was confirmed as being differentially expressed in the reverse subtraction and selected for further analysis in this paper.
###end p 53
###begin title 54
Northern analysis
###end title 54
###begin p 55
###xml 218 224 217 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al </italic>
###xml 225 227 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 242 248 241 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 393 398 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 511 513 510 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
15 mug of total RNA from 8 weeks, 12 weeks and full term human placenta were electrophoresed on 1% RNase-free agarose gel and Northern transferred to a nylon membrane according to according to the method from Sambrook et al [34]. A probe for SAMD9 was generated using PCR with 89729F and 88001R as primers for a 1729 bp fragment from the 3'UTR. The Northern membrane was first probed with the SAMD9, then stripped and probed with the human actin probe as a loading control. The probes were labeled with isotope 32P.
###end p 55
###begin title 56
Cloning of the full-length gene
###end title 56
###begin title 57
(1) 5'- and 3'- rapid amplification of cDNA ends (RACE)
###end title 57
###begin p 58
###xml 174 175 165 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 220 221 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 312 318 303 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
RACE was performed using SMARTtrade mark RACE cDNA synthesis kit (Clontech Inc., USA) according to the manufacture's instruction. The anti-sense (93769R, see Additional file 1) and the sense (93961F, see Additional file 1) primers for the 5'- and 3'- RACE were designed using the sequence of the 200 bp clone of SAMD9 isolated from suppression subtractive hybridization. The amplified transcripts were cloned into a pCR 2.1 vector (Invitrogen, USA), sequenced, and mapped to the DNA sequence in the GenBank.
###end p 58
###begin title 59
(2) Long-distance PCR, cloning and sequencing
###end title 59
###begin p 60
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 113 114 113 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
Sequences corresponding to the 5'- and the 3'- ends of the SAMD9 gene (106430F' and 87926R', see Additional file 1) or SAMD9L gene (136752F' and 119170R', see Additional file 1) were used as primers for long-distance PCR. The amplified transcripts were cloned into a pCR vector (Invitrogen, USA), and the insertion of the transcript was verified by restriction enzyme digestion and sequencing.
###end p 60
###begin title 61
###xml 9 14 <span type="species:ncbi:9606">human</span>
PCR with human multiple tissue cDNA panels
###end title 61
###begin p 62
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 436 437 436 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 456 461 456 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 517 523 517 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 525 531 525 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 82 87 <span type="species:ncbi:9606">human</span>
Expression of SAMD9 and its paralogous gene SAMD9L were investigated using PCR of human multiple tissue cDNA panels including adult, fetal and tumor tissues (Clontech, USA). The sequences at the 3' UTR of the SAMD9 and SAMD9L genes were used to design the target primers according to the instruction from the manufacture since the DNase pretreated RNA was used for synthesis of those cDNA panels. 88347F and 88001R [see Additional file 1] were primers for SAMD9, while 119622F and 119170R [see Additional file 1] for SAMD9L. GAPDH was used as a control.
###end p 62
###begin title 63
Semi-quantitative RT-PCR
###end title 63
###begin p 64
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 247 254 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M</italic>
###xml 313 321 313 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M </italic>
###xml 346 353 346 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M</italic>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 594 600 594 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 661 667 661 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 723 724 723 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 808 816 808 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M </italic>
###xml 834 839 834 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 219 224 <span type="species:ncbi:9606">human</span>
The total RNA was extracted from tumor tissue and normal control tissue from aggressive fibromatosis, breast and colon cancers using Trizol RNA reagents (Invitrogen, USA). The anti-sense and sense primers for SAMD9 and human beta-2 microglobulin (beta 2M) were designed using the sequence across the introns, and beta 2M was used as control. For beta 2M, beta 2M-F was used as sense primer and beta 2M-R as anti-sense primer to produce a 112 bp PCR product [see Additional file 1]. For SAMD9, 103270F was used as sense primer and 93871R as anti-sense primer to produce a 711 bp PCR product for SAMD9 with SAM domain coding sequence and a 222 bp PCR product for SAMD9 lacking SAM domain coding sequence [see Additional file 1]. The optimal amplification cycles were set within the linear range, 30 cycles for beta 2M and 37 cycles for SAMD9, after applying series of diluting cDNA samples and subjecting for series of PCR amplification cycles.
###end p 64
###begin p 65
###xml 238 246 238 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M </italic>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 477 485 477 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">beta 2M </italic>
The polymerase cycling reactions of paired cDNA samples were conducted at the same time for both target and control genes. The amplified products were electropheresed on a 2% agarose gel and photographed under UV light. The expression of beta 2M was set as control to normalize the level of target expression. The expression level of the target gene SAMD9 was analyzed using computer software ImageQuant and represented as the ratio of its intensity verse the intensity of the beta 2M gene under the condition that the same amount of the cDNA was applied as template for the target gene and the control gene.
###end p 65
###begin title 66
Real-time quantitative PCR
###end title 66
###begin p 67
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">28S</italic>
###xml 144 149 144 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 247 253 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 342 343 342 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 705 709 705 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">28S </italic>
###xml 737 743 737 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 746 752 746 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 776 778 776 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t </sub>
###xml 909 923 909 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916; C </sup>
###xml 923 925 915 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">t </sub>
###xml 933 935 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 978 984 970 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 987 994 979 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 105 110 <span type="species:ncbi:9606">human</span>
Real-time quantitative PCR was undertaken using 28S rRNA (28S) as the control gene. PCR primer pairs for human 28S rRNA were taken from Simpson et al, 2000 [35], for SAMD9, 103270F was used as sense primer and 94424R as anti-sense primer, and for SAMD9L, 133857F was used as sense primer and 124170R as anti-sense primer [see Additional file 1]. Validation curves were carried out for the primer sets using RNA from SW480 cells diluted to 1:5, 1:10, 1:50, 1:100, and 1:1000. Delta delta Ct method was used for setting up the experiment and analysis of the data. An arbitrarily designed threshold was set at 0.2 for all analysis, while the baseline cycles were set for all analysis from 3 to 10 cycles for 28S and from 3 to 30 cycles for SAMD9 or SAMD9L. The threshold cycle, Ct was determined using the analysis software (SDS 2.1, Applied Biosystems). The result was analyzed using the relative quantitative 2-DeltaDelta C t method [36]. The expression level of the target gene SAMD9 or SAMD9L in tumor tissues were represented as the fold difference from normal control tissues.
###end p 67
###begin title 68
Generation of expression vectors
###end title 68
###begin title 69
(1) Long distance PCR amplification of SAMD9 or SAMD9L open reading frame
###end title 69
###begin p 70
###xml 63 69 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 278 279 278 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 331 338 331 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
The sequences flanking the predicted open reading frame of the SAMD9 or SAMD9L gene were used as primers. For SAMD9, 94504F was the sense primer and 89735R was the anti-sense primer, while 124378F as sense primer and 119624R as anti-sense primer for SAMD9L [see Additional file 1]. The predicted open reading frame of the SAMD9 or SAMD9L was subcloned into pDNR-1r donor vector using standard methods [34]. The correct orientation of the insert was confirmed by restriction enzyme digestion and sequencing to generate pDNR-1r-SAMD9-ORF, pDNR-1r-SAMD9L-ORF-major and pDNR-1r-SAMD9L-ORF-minor.
###end p 70
###begin p 71
###xml 151 154 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The pDNR-1r-SAMD9-ORF, pDNR-1r-SAMD9L-ORF-major and pDNR-1r-SAMD9L-ORF-minor were subcloned into several acceptor vectors, such as pLP-EGFP-C1 and pLP-CMV-HA (Clontech, USA), using Clontech Creatortrade mark DNA cloning kit (PT3460-2, Clontech, USA) with Cre recombinase through Cre-loxP site-specific recombination to catalyze the transfer of the open reading frame from pDNR-1r donor vector to the acceptor vectors according to the manufacture's instruction.
###end p 71
###begin title 72
Western blot analysis with anti-GFP
###end title 72
###begin p 73
###xml 800 806 800 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 870 872 870 872 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd</sup>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1116 1122 1116 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 578 583 <span type="species:ncbi:10090">mouse</span>
The total protein from Cos-1 cells transfected with either pLP-EGFP-SAMD9 or its control vector pLP-EGFP were harvested using Nonidet P-40 lysis buffer (1% Nonidet P-40, 50 mM Tris-HCL [pH 7.5], 150 mM NaCl, 2 mM EDTA, 10% glycerol, proteinase inhibitor tablet [1 tablet per 10 mL buffer, Roche, USA]). The protein was electropheresed on 8% sodium dodecyl sulphacrylamide gel and transferred to membrane according to the method from Sambrook et al, 1989. The membrane was then probed with anti-GFP (1:200, Santa Cruz, USA) and secondary antibody (HRP-conjugated monoclonal anti-mouse IgG, 1:2000, Transduction Laboratory, USA). Finally, the membrane was exposed to X-ray film for 20 minutes. The total protein from Cos-1 cells transiently co-transfected with pLP-EGFP-SAMD9 and either one of the two SAMD9 RNA interference vectors (pSUPER-RNAi-SAMD9, pSUPER-RNAi-SAMD9-2nd), RNA interference vector with mutated SAMD9 sequence (pSUPER-RNAi-SAMD9-mut9) to null its function as negative control, or its control empty vector (pSUPER-RNAi-EGFP) were also harvested for Western blot analysis to confirm the knock-down of SAMD9 expression by RNA interference.
###end p 73
###begin title 74
Generation of RNA inference vector for SAMD9
###end title 74
###begin p 75
###xml 170 176 170 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 297 303 297 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 384 385 384 385 <underline xmlns:xlink="http://www.w3.org/1999/xlink">A</underline>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">th </sup>
###xml 480 486 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 670 676 670 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 807 813 807 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 857 859 857 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd</sup>
After searching of the public available sequence database, a 19 bp oligonucleotide sequence (846 bp after the start of translation) specific for the RNA inference of the SAMD9 expression was found (5'-GTGCATTCGAGAGCCAAGA-3') and subcloned into a pSUPER-RNAi-EGFP expression vector to generate the SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9). A nucleotide substitution from G to A at the 9th position of this 19 bp oligonucleotide results in abolishing of its specificity to SAMD9 to generate the negative control vector (pSUPER-RNAi-SAMD9-mut9). Another 19 bp oligonucleotide sequence (2371 bp after the start of translation) specific for the RNA inference of the SAMD9 expression was found (5'-TACGTACCTGTACTACTCC-3') and also subcloned into a pSUPER-RNAi-EGFP expression vector to generate a second SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9-2nd).
###end p 75
###begin title 76
Cell culture, gene transfection, selection, flow cytometry cell sorting, immunoflurescent staining and confocal microscopy
###end title 76
###begin p 77
###xml 125 127 125 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 441 447 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 574 580 568 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 708 714 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 89 93 <span type="species:ncbi:9913">calf</span>
###xml 680 683 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
SW480, MRC-5, or Cos-1 cells (ATCC, USA) were cultured in the DMEM medium with 10% fetal calf serum (Invitrogen, USA) in a CO2 incubator at 37degreesC. Gene transfection was conducted using Fugene 6 reagent (Roche, USA). The transfected cells were either harvested for transient transfection or selected with the addition of 200 ng of G418 (Sigma, USA) for 2 weeks, and sorted by flow cytometry using GFP as marker. The cellular location of SAMD9 was analyzed under a confocal microscope in Cos-1, MRC-5 and SW480 cells transfected with pLP-EGFP-SAMD9. The effectiveness of SAMD9 RNA interference was documented by using confocal microscopy in SW480 cells co-transfected with pLP-CMV-HA-SAMD9 and either the SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9) or its empty control vector (pSUPER-RNAi-EGFP), which were fixed, stained with anti-HA (1:200, Santa Cruz, USA) and Tex-red conjugated secondary antibody (1:100, Molecular Probes, USA).
###end p 77
###begin title 78
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro assays
###end title 78
###begin title 79
(1) Cell proliferation assay
###end title 79
###begin p 80
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 343 345 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 101 107 <span type="species:ncbi:9913">bovine</span>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
Cells were seeded at the 2.5 x 104 cells/mL on glass cover slips and cultured in DMEM with 10% fetal bovine serum at 37degreesC. S-phase cells were labelled overnight by supplementation of the cell culture medium with BrdU (Sigma, St louis, MO; 10 muM) and detected by mouse monoclonal anti-BrdU (DAKO, Demark; 1:100) as the published method [37]. After the final step, the glass cover slips were removed from the well and mounted on microscope slides by mounting medium with DAPI to stain the nuclei. The number of S-phase cells and total number of nuclei were counted over five fields at center and four corners on the glass cover slip at 100x magnification. Each experiment was conducted nine times.
###end p 80
###begin title 81
(2) Cell motility and invasion assays
###end title 81
###begin p 82
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 129 133 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 195 199 187 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 75 81 <span type="species:ncbi:9913">bovine</span>
Cells were seeded at 5 x 104 cells/mL and cultured with DMEM and 10% fetal bovine serum for 22 hours at 37degreesC in the BioBoat(R) culture inserts (BD Bioscience) for motility assay and BioBoat(R) Matrigel invasion chambers (BD Bioscience) for invasion assay. After the incubation period, cells on the upper surface of the membrane were removed, but cells that migrated to the lower surface of the membrane were fixed to the membrane with 4% paraformaldehyde. The membranes were then excised from the insert and mounted on microscope slides by mounting medium with DAPI to stain the nuclei. The total number of nuclei was counted in each of five fields across the diameter of the member viewed at 400x magnification using UV fluorescence microscopy. The experiments were conducted nine times.
###end p 82
###begin title 83
(3) Cell apoptosis assay
###end title 83
###begin p 84
Cell apoptosis activity was studied using caspase-3 colorimetric activity assay kit (Chemicon International, USA). The experiments were conducted nine times and relative caspase-3 activity was represented as percentage changes of the treatment group to the control group and calculated by dividing the optical density reading of the treatment group to the control group and multiplying 100.
###end p 84
###begin title 85
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Xenograft in immune deficient mice
###end title 85
###begin title 86
(1) SW480
###end title 86
###begin p 87
###xml 155 156 155 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 169 170 169 170 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 416 422 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 231 240 <span type="species:ncbi:10090">nude mice</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 395 398 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 473 476 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
The flow cytometry sorted SW480 cells transfected with either pLP-EGFP-SAMD9 or its control vector pLP-EGFP were suspended in 1x PBS (120 mM NaCl, 10 mM Na2HPO4, 3 mM KH2PO4, pH 7.3) and injected underneath the skin on the back of nude mice and NOD-SCID mice at a concentration of 2.5 million cells per injection. A similar explant was performed using sorted SW480 cells co-transfected with pLP-CMV-HA-SAMD9 and the SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9) or pLP-CMV-HA-SAMD9 and the empty control vector (pSUPER-RNAi-EGFP). The mice were sacrificed after 1 week of injection and the size of tumors were blindly scored.
###end p 87
###begin title 88
(2) MRC-5
###end title 88
###begin p 89
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
The flow cytometry sorted MRC-5 cells transfected with the SAMD9 RNA interference vector (pSUPER-RNAi-SAMD9) or the empty control vector (pSUPER-RNAi-EGFP) were also suspended in 1x PBS and injected underneath the skin on the back of NOD-SCID mice at a concerntration of 5.9 million cells per injection. The mice were sacrificed after 1 week of injection and the size of tumors were blindly scored.
###end p 89
###begin title 90
Statistical analysis
###end title 90
###begin p 91
The counting process was conducted by a blinded observer. Means and 95% confidence intervals were calculated. The t-test was applied to compare differences.
###end p 91
###begin title 92
New sequence accession numbers
###end title 92
###begin p 93
GenBank: , , , , .
###end p 93
###begin title 94
Authors' contributions
###end title 94
###begin p 95
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 348 355 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 428 435 428 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 582 588 582 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 649 655 649 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
CFL carried out the subtraction hybridization, the initial experiments cloning the genes, generating the expression and siRNA constructs, and drafting the manuscript, JRM carried out the analysis of the genes in different species, and assisted in drafting the manuscript. RYW carried out experiments to determine the expression levels of SAMD9 and SAMD9L in normal and tumor tissues, JR carried out experiments to determine the SAMD9L splice variants, KL carried out gene transfection experiments, CK carried out cell proliferation experiments, RK carried out experiments to detect SAMD9 using Western analysis, SB carried out experiments to detect SAMD9 using Northern analysis, SWS carried out the analysis of the localization on chromosome seven, participated in the design of the study, and assisted with the draft of the manuscript. BAA conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 95
###begin title 96
Supplementary Material
###end title 96
###begin title 97
Additional file 1
###end title 97
###begin p 98
Supplementary Results and a summary of Primers used in the cloning of these genes. The data provided represents additional details on the structure and splice variants of SAMD9 and SAMD9L. In addition, there is a table listing the PCR primers used in this work.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Acknowledgements
###end title 100
###begin p 101
###xml 286 294 <span type="species:ncbi:9606">patients</span>
We appreciate the help of Andrew Boright for the bioinformatics analysis. We would like to acknowledge Dr. Irene Andrulis and Dr. Steven Gallinger, The Samuel Lunenfeld Research Institute, University of Toronto for providing us the normal and tumor samples from breast and colon cancer patients; Dr. Reuven Agami, Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, Netherlands, for giving us the construct to stable express short interfering RNA in mammalian cells (pSUPER); and Paul Barnfield and Eric Arruda for providing us pSUPER-RNAi-EGFP expression vector. This work was funded by the National Cancer Institute of Canada, the Canadian Institute of Health Research, and the Canadian Research Chairs Program.
###end p 101
###begin article-title 102
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts
###end article-title 102
###begin article-title 103
Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells
###end article-title 103
###begin article-title 104
Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder
###end article-title 104
###begin article-title 105
Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
###end article-title 105
###begin article-title 106
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)
###end article-title 106
###begin article-title 107
Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor)
###end article-title 107
###begin article-title 108
Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor)
###end article-title 108
###begin article-title 109
###xml 96 102 <span type="species:ncbi:10090">murine</span>
Matrix metalloproteinase activity modulates tumor size, cell motility, and cell invasiveness in murine aggressive fibromatosis
###end article-title 109
###begin article-title 110
Plasminogen activator inhibitor-1 (PAI-1) modifies the formation of aggressive fibromatosis (desmoid tumor)
###end article-title 110
###begin article-title 111
Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
###end article-title 111
###begin article-title 112
Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
###end article-title 112
###begin article-title 113
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences
###end article-title 113
###begin article-title 114
Database resources of the National Center for Biotechnology
###end article-title 114
###begin article-title 115
CD-Search: protein domain annotations on the fly
###end article-title 115
###begin article-title 116
Recent improvements to the PROSITE database
###end article-title 116
###begin article-title 117
PROSITE: a documented database using patterns and profiles as motif descriptors
###end article-title 117
###begin article-title 118
ScanProsite: a reference implementation of a PROSITE scanning tool
###end article-title 118
###begin article-title 119
PHD: predicting one-dimensional protein structure by profile based neural networks
###end article-title 119
###begin article-title 120
The RNA-binding SAM domain of Smaug defines a new family of post-transcriptional regulators
###end article-title 120
###begin article-title 121
###xml 28 33 <span type="species:ncbi:9606">human</span>
Oligomeric structure of the human EphB2 receptor SAM domain
###end article-title 121
###begin article-title 122
A system for stable expression of short interfering RNAs in mammalian cells
###end article-title 122
###begin article-title 123
University of California at Santa Cruz genome browser
###end article-title 123
###begin article-title 124
European Bioinformatics Institute website
###end article-title 124
###begin article-title 125
Multiple sequence alignment with the Clustal series of programs
###end article-title 125
###begin article-title 126
A molecular timescale for vertebrate evolution
###end article-title 126
###begin article-title 127
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis
###end article-title 127
###begin article-title 128
Analysis of canonical and non-canonical splice sites in mammalian genomes
###end article-title 128
###begin article-title 129
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Human-mouse comparative mapping of the genomic region containing CDK6: localization of an evolutionary breakpoint
###end article-title 129
###begin article-title 130
###xml 4 8 <span type="species:ncbi:10090">mice</span>
Why mice have lost genes for COL21A1, STK17A, GPR145 and AHRI: evidence for gene deletion at evolutionary breakpoints in the rodent lineage
###end article-title 130
###begin article-title 131
###xml 16 21 <span type="species:ncbi:9606">human</span>
Implications of human genome architecture for rearrangement-based disorders: the genomic basis of disease
###end article-title 131
###begin article-title 132
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine segmental duplications are hot spots for chromosome and gene evolution
###end article-title 132
###begin article-title 133
Structural dynamics of eukaryotic chromosome evolution
###end article-title 133
###begin article-title 134
###xml 73 83 <span type="species:ncbi:10116">norway rat</span>
Recent segmental duplications in the working draft assembly of the brown norway rat
###end article-title 134
###begin article-title 135
Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR
###end article-title 135
###begin article-title 136
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 136
###begin article-title 137
Immunocytochemical analysis of chromaffin cell proliferation in vitro
###end article-title 137
###begin title 138
Figures and Tables
###end title 138
###begin p 139
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 40 46 40 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Gene and protein structure of <italic>SAMD9 </italic>and <italic>SAMD9L</italic></bold>
###xml 48 51 48 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 232 235 232 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 246 253 246 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
Gene and protein structure of SAMD9 and SAMD9L. A. Diagram of SAMD9 gene structure and predicted protein structure. Exons are shown as red rectangles. The protein is shown in green, with the sterile alpha motif domain as blue oval. B. Diagram of SAMD9L gene structure and predicted protein structure. Exons are shown in red. The protein is shown as a pink box, with two predicted open reading frames of shown. The sterile alpha motif domain is shown as blue oval. A potential nuclear localization domain is shown as grey box.
###end p 139
###begin p 140
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of <italic>SAMD9 </italic>and <italic>SAMD9L </italic>in multiple tissue types</bold>
###xml 57 60 57 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 227 230 227 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 334 339 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 351 357 351 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 369 375 369 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 124 129 <span type="species:ncbi:9606">human</span>
###xml 211 216 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:9606">Human</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 458 463 <span type="species:ncbi:9606">human</span>
###xml 640 645 <span type="species:ncbi:9606">human</span>
###xml 702 707 <span type="species:ncbi:9606">human</span>
Expression of SAMD9 and SAMD9L in multiple tissue types. A. Northern blot from total RNA of 8 weeks, 12 weeks and full term human placenta probed with 3'UTR of SAMD9. A 7 kb transcript was detected in full term human placenta. B. Human adult, fetal, and tumor multiple tissue cDNA panels were amplified with the sequences at 3'UTR of SAMD9, SAMD9L or GAPDH as primers. SAMD9 was expressed in all human adult, fetal and tumor tissues that were available from human multiple tissue cDNA panels except for fetal brain and breast cancer. It was expressed at a very low level in skeletal muscle and pancreatic cancer. SAMD9L is expressed in all human adult, fetal and tumor tissues that were available from human multiple tissue cDNA panels, except breast cancer, colon cancer, and pancreatic cancer.
###end p 140
###begin p 141
###xml 29 35 29 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 39 46 39 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lower level of expression of <italic>SAMD9 </italic>and <italic>SAMD9L </italic>in neoplasia</bold>
###xml 60 63 60 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 158 163 158 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 403 406 403 406 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 447 454 447 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L</italic>
###xml 510 517 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 618 625 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 738 741 738 741 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 769 774 769 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 776 782 776 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 1024 1027 1024 1027 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D. </bold>
###xml 1080 1087 1080 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 393 401 <span type="species:ncbi:9606">patients</span>
###xml 729 737 <span type="species:ncbi:9606">patients</span>
###xml 878 886 <span type="species:ncbi:9606">patients</span>
Lower level of expression of SAMD9 and SAMD9L in neoplasia. A. Validation curves for the primer sets of SAMD9 and 28S rRNA, and real time quantitative PCR of SAMD9. SAMD9 and 28S rRNA have similar amplification efficiency since the slope was very similar for both curves. SAMD9 was expressed at a lower level in aggressive fibromatosis (AF) tumors compared to normal fibrous tissues from same patients. B. Validation curves for the primer sets of SAMD9L and 28S rRNA, and real time quantitative PCR of SAMD9L. SAMD9L and 28S rRNA have similar amplification efficiency since the slope was very similar for both curves. SAMD9L was expressed at a lower level in breast cancers compared to normal breast epithelial tissues from same patients.C. Semi-quantitative RT-PCR of SAMD9. SAMD9 was under-expressed in some cases of colon cancer compared to the normal colon mucosa from same patients. Real time PCR data showed no significant difference in expression level between breast and colon cancer and normal controls as a group. D. There was no significant difference in expression of SAMD9L between aggressive fibromatosis samples and normal controls tissues.
###end p 141
###begin p 142
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SAMD9 </italic>protein is expressed and localized to the cytoplasm</bold>
###xml 59 62 59 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 118 124 118 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 222 228 222 228 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B, C. </bold>
###xml 242 248 242 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 385 388 385 388 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 406 409 406 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 447 456 447 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D, E, F. </bold>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 532 538 532 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 581 584 581 584 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D. </bold>
###xml 648 651 648 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E. </bold>
###xml 713 716 713 716 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F. </bold>
SAMD9 protein is expressed and localized to the cytoplasm. A. Western analysis for the SAMD9-EGFP fusion protein. The SAMD9 fusion protein was detected as a predicted 200 kDa band in Cos-1 cells, using an antibody to GFP. B, C. Expression of SAMD9 putative protein in MRC-5 cells. N-terminal EGFP tagged SAMD9 was detected in the cytoplasm of MRC-5 cells when transiently transfected. B. Light field view. C. Fluorescent microscopy view for FITC. D, E, F. Expression of SAMD9 putative protein in SW480 cells. N-terminal EGFP tagged SAMD9 localized to the cytoplasm of SW480 cells. D. Fusion protein detected under fluorescent wave length for FITC. E. Cell nucleus detected under fluorescent wave length for DAPI. F. Merged view of image D and E.
###end p 142
###begin p 143
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 0 34 0 34 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SAMD9 </italic>regulates cell proliferation</bold>
###xml 36 39 36 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 48 54 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 122 128 122 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 364 366 364 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">nd</sup>
###xml 468 473 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 475 478 475 478 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 507 513 507 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 540 546 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 593 596 593 596 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
SAMD9 regulates cell proliferation. A. RNAi for SAMD9 is effective in reducing protein expression. A 200 kDa band for the SAMD9 fusion protein was detected in Cos-1 cells after co-transfection of pLP-EGFP-SAMD9 with either pSUPER-RNAi-SAMD9-mut9 or pSUPER-RNAi-EGFP, but it is not detected after co-transfection with either pSUPER-RNAi-SAMD9 or pSUPER-RNAi-SAMD9-2nd. The expression of the EGFP-SAMD9 fusion protein was reduced in Cos-1 cells with RNA interference of SAMD9. B. Semi-quantitative RT-PCR for SAMD9 expression in MRC-5 cells. SAMD9 expression was reduced after RNA interference. C. Proliferation rate (Brdu incorporation percent) increased after RNA interference of SAMD9 in MRC-5 cells.
###end p 143
###begin p 144
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 0 24 0 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>SAMD9 </italic>reduces tumor size</bold>
###xml 26 29 26 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A. </bold>
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 140 143 140 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 167 173 167 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 216 219 216 219 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C. </bold>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 292 301 292 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D and E. </bold>
###xml 388 394 388 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 428 429 428 429 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 449 450 449 450 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 417 426 <span type="species:ncbi:10090">nude mice</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
SAMD9 reduces tumor size. A. Increased expression of SAMD9 reduced SW480 cell proliferation rate as detected by Brdu incorporation percent. B. Increased expression of SAMD9 reduced the invasion index of SW480 cells. C. Increased expression of SAMD9 increased caspase activity in SW480 cells. D and E. The tumor volume formed from SW480 xenografts was reduced with increased expression of SAMD9 when transplanted into nude mice (D) or Nod-scid mice (E).
###end p 144
###begin p 145
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 0 134 0 134 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Diagram for the genomic region encompassing the loci of <italic>SAMD9 </italic>and <italic>SAMD9L </italic>in human, mouse and rat along with the segmental duplications</bold>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9</italic>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 93 96 <span type="species:ncbi:10116">rat</span>
###xml 623 628 <span type="species:ncbi:10090">mouse</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
###xml 771 774 <span type="species:ncbi:10116">rat</span>
Diagram for the genomic region encompassing the loci of SAMD9 and SAMD9L in human, mouse and rat along with the segmental duplications. Exons are shown as a red box. Segmental duplications are shown as orange, green, blue and grey boxes. Two orange segmental duplications may mediate chromosomal breakage with subsequent deletion of SAMD9, and the centromeres of chromosome 6 and 5 are formed at the sites of breakage. The grey segmental duplications, sharing the sequence among numerous centromeric loci, are accumulated at the centromere of chromosome 5. The green and blue segmental duplications flanking the SAMD9L are mouse specific based on sequence similarity, while the orange and grey segments have occurred at about the same time as the divergence of mouse and rat.
###end p 145
###begin p 146
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9 </italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SAMD9L </italic>
Summary of orthologous genes of SAMD9 and SAMD9L in multiple species
###end p 146
###begin p 147
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a </sup>
###xml 55 57 55 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b </sup>
a There is no match in protein or nucleotide database. b There is best reciprocal nucleotide match found in genomic sequence.
###end p 147

